| HALLMARK HYPOXIA |
0.00 |
0.00 |
0.00 |
| HALLMARK EPITHELIAL MESENCHYMAL TRANSITION |
0.00 |
0.00 |
0.00 |
| HALLMARK TNFA SIGNALING VIA NFKB |
0.00 |
0.00 |
0.00 |
| HALLMARK INFLAMMATORY RESPONSE |
0.00 |
0.00 |
0.00 |
| HALLMARK IL2 STAT5 SIGNALING |
0.00 |
0.00 |
0.00 |
| HALLMARK UV RESPONSE DN |
0.00 |
0.00 |
0.00 |
| HALLMARK KRAS SIGNALING UP |
0.00 |
0.00 |
0.00 |
| HALLMARK MTORC1 SIGNALING |
0.00 |
0.00 |
0.00 |
| HALLMARK UNFOLDED PROTEIN RESPONSE |
0.00 |
0.00 |
0.01 |
| HALLMARK GLYCOLYSIS |
0.00 |
0.00 |
0.02 |
| HALLMARK ALLOGRAFT REJECTION |
0.00 |
0.01 |
0.05 |
| HALLMARK ANDROGEN RESPONSE |
0.01 |
0.02 |
0.16 |
| HALLMARK WNT BETA CATENIN SIGNALING |
0.02 |
0.02 |
0.17 |
| HALLMARK P53 PATHWAY |
0.00 |
0.03 |
0.28 |
| HALLMARK MYC TARGETS V1 |
0.01 |
0.04 |
0.35 |
| HALLMARK COMPLEMENT |
0.02 |
0.05 |
0.45 |
| HALLMARK APOPTOSIS |
0.02 |
0.07 |
0.54 |
| HALLMARK MYC TARGETS V2 |
0.06 |
0.07 |
0.58 |
| HALLMARK APICAL JUNCTION |
0.03 |
0.08 |
0.64 |
| HALLMARK PI3K AKT MTOR SIGNALING |
0.08 |
0.10 |
0.75 |
